Multiple sclerosis: open trials in Argentina

• NCT06846281

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Buenos Aires · Novartis Investigative Site, CABA · Novartis Investigative Site, Rosario

  Registry updated 2026-10-26

• NCT07161258

  A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

  Trial Treatment · Phase 2 · Hoffmann-La Roche

  INECO Neurociencias Oroño, Rosario · Sanatorio del Sur S.A., San Miguel de Tucumán

  Registry updated 2026-10-13

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Bombal · Novartis Investigative Site, Buenos Aires · Novartis Investigative Site, CABA · Novartis Investigative Site, Capital Federal · Novartis Investigative Site, Rosario · Novartis Investigative Site, San Juan · Novartis Investigative Site, San Miguel de · Novartis Investigative Site, Santiago del Estero

  Registry updated 2026-10-13

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error